| Carcinoid tumor and intravenous octreotide infusion during labor and delivery. | |
| | |
MedLine Citation:
|
PMID: 19200714 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
There are limited numbers of reports concerning the management of pregnancy complicated by carcinoid tumors. Octreotide, the synthetic analogue of somatostatin, has been found to be beneficial in preventing the perioperative exacerbation of carcinoid syndrome. We present a case of the successful use of neuraxial analgesia/anesthesia for labor and vaginal delivery in a symptomatic parturient afflicted with carcinoid syndrome, who received an intravenous infusion of octreotide throughout labor and vaginal delivery. |
| | |
Authors:
|
B T Le; S Bharadwaj; A M Malinow |
Related Documents
:
|
19804274 - Diagnosis and management of marfan syndrome. 8116614 - Severe neonatal marfan syndrome resulting from a de novo 3-bp insertion into the fibril... 3662324 - Ocular findings in mitral valve prolapse syndrome. 12831714 - Marfan syndrome: screening for sudden death in athletes. 16299044 - A case of post-reperfusion syndrome following surgery for liver trauma. 20351214 - Characterization of three staphylococcus aureus isolates from a 17-year-old female who ... |
Publication Detail:
|
Type: Case Reports; Journal Article Date: 2009-02-05 |
Journal Detail:
|
Title: International journal of obstetric anesthesia Volume: 18 ISSN: 1532-3374 ISO Abbreviation: Int J Obstet Anesth Publication Date: 2009 Apr |
Date Detail:
|
Created Date: 2009-03-23 Completed Date: 2009-06-26 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9200430 Medline TA: Int J Obstet Anesth Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 182-5 Citation Subset: IM |
Affiliation:
|
Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Anesthesia, Obstetrical* Anesthesia, Spinal* Antineoplastic Agents, Hormonal / administration & dosage, therapeutic use* Carcinoid Tumor / complications*, drug therapy* Delivery, Obstetric Female Humans Infant, Newborn Infusions, Intravenous Octreotide / administration & dosage, therapeutic use* Pregnancy Pregnancy Complications, Neoplastic / drug therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents, Hormonal; 83150-76-9/Octreotide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Fulminant peripartum cardiomyopathy rescue with extracorporeal membranous oxygenation.
Next Document: Crystal structure analysis of DNA lesion repair and tolerance mechanisms.